Thus, the development of a rapid and practical immunosensor for the detection of the cTnT in serum samples from patients with myocardial infarction is desirable due to its roles in cardiospecific diagnosis, risk stratification, prognostic risk assessment, and therapeutic choices. This evidence concerns the gene TNNT2 and myocardial infarction.